# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001437749-21-010493
Filing Date
2021-04-30
Accepted
2021-04-30 17:15:29
Documents
6
Period of Report
2021-06-18

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM DEF 14A | bioli20210428_def14a.htm | DEF 14A | 504807
2 |  | a01.jpg | GRAPHIC | 242977
3 |  | a02.jpg | GRAPHIC | 172728
4 |  | a03.jpg | GRAPHIC | 233664
5 |  | a04.jpg | GRAPHIC | 199447
6 |  | bllogo01.jpg | GRAPHIC | 10994
| Complete submission text file | 0001437749-21-010493.txt |  | 1690317

Mailing Address 3303 MONTE VILLA PARKWAY SUITE 310 BOTHELL WA 98021
Business Address 3303 MONTE VILLA PARKWAY SUITE 310 BOTHELL WA 98021 4254011400
BIOLIFE SOLUTIONS INC (Filer) CIK: 0000834365 (see all company filings)

EIN.: 943076866 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36362 | Film No.: 21879701
SIC: 3845 Electromedical & Electrotherapeutic Apparatus